A Novel Stuttering Disfluency Classification System Based on Respiratory Biosignals.

Stuttering is the principal fluency disorder that affects 1% of the world population. Growing with this disorder can impact the quality of life of the adults who stutter (AWS). To manage this condition, it is necessary to measure and assess the stuttering severity before, during and after any therapeutic process.